| 000 | 01197 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514023205.0 | ||
| 264 | 0 | _c20020926 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a1465-6566 | ||
| 024 | 7 |
_a10.1517/14656566.2.11.1751 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCrossman, D C | |
| 245 | 0 | 0 |
_aOpportunities for the treatment of inflammation in cardiovascular disease. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cNov 2001 |
||
| 300 |
_a1751-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aArteriosclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aCD40 Antigens _xphysiology |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xphysiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTranscription Factors _xphysiology |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 2 _gno. 11 _gp. 1751-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2.11.1751 _zAvailable from publisher's website |
| 999 |
_c11734917 _d11734917 |
||